Skip to main content
Veterinary Medicines

INMEVA, SUSPENSION FOR INJECTION

Authorised
  • Chlamydia abortus, strain A22, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Abortusovis, strain Sao, Inactivated

Product identification

Medicine name:
INMEVA, SUSPENSION FOR INJECTION
INMEVA, suspensie voor injectie
Active substance:
  • Chlamydia abortus, strain A22, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Abortusovis, strain Sao, Inactivated
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Chlamydia abortus, strain A22, Inactivated
    1.00
    relative potency
    /
    1.00
    unit(s)
  • Salmonella enterica, subsp. enterica, serovar Abortusovis, strain Sao, Inactivated
    1.00
    relative potency
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Polyethylene (PET) vials of 10ml
  • Polyethylene (PET) vials of 250ml
  • Polyethylene (PET) vials of 100ml
  • Polyethylene (PET) vials of 50ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 123318
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0350/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 20/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."